17-18 May 2022
Tues-Wed
Boston, MA

16th Drug Discovery

Innovation Programme

About Drug Discovery Innovation Programme 2022





This year’s Drug Discovery Innovation Programme will highlight the challenges discovery pipelines have faced due to COVID-19 and will put a spotlight on the adoption of technology to finding the solutions.
With over 100+ attendees, learn how modernization in R&D processes is fundamentally changing what the drug discovery research will look like in the next two to five years.
So, join us in May 2022 for an in-person experience and 2-days of top-level strategic content and the current scientific insights, networking, and discussions from leading global pharmaceutical R&D executives.

Drug Discovery Innovation Programme Key Topics

ROAD TO AI

LEAD GENERATION STRATEGIES

BOOSTING IMMUNOTHERAPY

ADVANCES IN DRUG DESIGN

RNA THERAPEUTICS ON THE RISE

SMALL MOLECULES IN DRUG DISCOVERY

TRANSLATING OMICS INTO THERAPEUTICS

PRECLINICAL STRATEGIES, MODELS AND TOOLS

COLLABORATE TO ACCELERATE

HIT TRIAGE AND VALIDATION STRATEGIES

MEDICINAL CHEMISTRY TOOLBOX

NOVEL DRUG TARGET DISCOVERY & VALIDATION





Why Attend Drug Discovery Innovation Programme





Reconnecting with Peers
Have you ever experienced the situation where working through a challenge over email, conference calls or other distance communication channels seems to take a lot of back and forth with no resolution in sight?


Meeting New Prospects
If your goal at an industry event is to meet new prospective clients and partners, there is really no substitute for the in-person experience. Attend WBI’s in-person conferences to meet new prospects and build your clientage.


Brand Building
If part of your company’s brand positioning is to be a true leader in the industry, attending World BI’s events can be a powerful way to send that message.




Getting a Handle on the Market
While virtual events can certainly deliver planned content (sessions, presentations, panel discussions, etc.) quite well, you will still need to meet your peers in-person to get a handle on the current market news.


Driving New Business
Even in industries with longer sales cycles, World BI’s in-person events is the place where new business deals are completed.


Enhance Engagement
WBI’s in-person events will help bring decision makers on your table by identifying their requirements and tailoring your services to offer the most relevant and valuable services to them and thus boosting engagement.
0

Discussion Topics

0

Speakers

0

Attendees

0

Networking Hours

Experts Panel

Meet our professonals



John Doe

Mohamed ElSayed, Ph.D

Research Fellow | Formulation/Delivery Group Leader | Founding Oral Peptide Delivery Platform Leader

Eli Lilly and Company

John Doe

Mauricio Terrones

CEO

Gabather

John Doe

Shruthi Bharadwaj, Ph.D

Strategic and Technical Advisor, Chief Data & AI Office

Novartis

Rafael

Rafael Depetris

Principal Scientist II, Lead of Structure Based Drug Design

Kadmon Holdings, Inc.

Tomi

Tomi Sawyer

Chief Drug Hunter & President

Maestro Therapeutics

Linda A. Lieberman

Principal Scientist, Experimental Biology

Merck

Who Will Attend

Delegates Will Include VPs, CEOs, CSOs, CTOs, Global Heads, Directors, Managers



Bioinformatics
Innovation
Research
R&D Senior Scientist
Computational Chemist
Principal Research Scientist
Translational oncology
Data Scientist
Non-Clinical Development
Biology
Early Development
Non-Clinical Biostatistics
Translational Immunology
Pharmaceutical Research
Discovery R&D
Senior Scientist
Medical Chemistry
Analytical Sciences
Machine Learning Research
Intelligent Systems Laboratory

Expert Interview



John Doe

Krishna Kanumuri

CEO

SAI LIFE SCIENCES LTD

View Complete Interview
TESTIMONIALS

what people say

“One-on one meetings are very good, very informal, relax and gives you very nice partnering opportunities.”

CO-FOUNDER 3Z ehf
“I've been able to meet people, potential customers and partners. The event saves you time and effort especially for the networking and the business development in our case.”
Sr. Director of business Development. Nuchem Therapeutics
“I liked the networking where you could meet lot of people and have one-on-one meeting.”
VP Pharmacology TocopheR

Exquisite Venue

Boston

Current & Past Sponsors

companies that support us



Events Gallery

see what we did lately

Book with us

@example.com